CMB
Click for more information
1.27% 39.0¢ cambium bio limited

Ann: Regeneus to be granted new patent to target pain in Japan, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. Biotechasx
    173 Posts.
    lightbulb Created with Sketch. 53
    clock Created with Sketch.
    09/02/21
    09:30
    Post #: 50815524
    Bang, bang.
    From inflammation to pain treatment, RGS, through its Progenza platform, now holds multiple patents in Japan for the use of Mesenchymal Stem Cells.
    Then, Sygenus will be added, for the use of stem cells secretions.
    Very good news. This will only strengthen Kyocera's commercial position in the Japanese market.
    RGS Price at posting: 10.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Exciting new copper-gold discoveries at Tarraji-Yampi: Dive into the strong drilling results now
right-arrow Created with Sketch.
NEWS Gold mineralisation discovered along major shear zone at Challa Gold Project, confirming two new intersections in latest aircore drilling
right-arrow Created with Sketch.
NEWS Antler Copper Project hits major permitting milestone – air quality permit advances to final review
right-arrow Created with Sketch.
LU7 Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
right-arrow Created with Sketch.
NEWS Step out drilling confirms high-grade cobalt & associated copper at Bald Hill
right-arrow Created with Sketch.
NEWS Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CMB (ASX) to my watchlist
(20min delay)
Last
39.0¢ 		Change
-0.005(1.27%) 		Mkt cap ! $4.653M
Open High Low Value Volume
39.0¢ 39.0¢ 39.0¢ $0 1

Buyers (Bids)

No. Vol. Price($)
1 2780 36.0¢
 

Sellers (Offers)

Price($) Vol. No.
38.5¢ 1 1
View Market Depth
Last trade - 12.00pm 07/10/2024 (20 minute delay) ?
CMB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.